The Protein Engineering Market is expanding as pharmaceutical and biotechnology companies increase their focus on engineered proteins, tailored biologics, and advanced therapeutic development. The market is projected to grow from USD 3.84 billion in 2025 to USD 15.73 billion by 2035, registering a CAGR of 15.0% during 2026–2035.

Advances in computational protein design, artificial intelligence, directed evolution, and structure-guided engineering are transforming conventional protein development workflows. These technologies can help researchers identify promising candidates more efficiently while reducing the number of experimental iterations required during discovery and optimization.

Monoclonal antibodies accounted for 37.4% of market revenue in 2025, while consumables generated USD 1.87 billion. Rational design remained the leading technology with a 52.4% share, whereas hybrid design is projected to be one of the fastest-growing approaches through 2035.

North America held 41.7% of revenue in 2025, supported by strong biopharmaceutical activity and research investment. Asia-Pacific is expected to record the fastest growth at an 18.2% CAGR, creating opportunities through expanding CRO capacity, domestic biologics development, and increasing biotechnology investment.

Gain valuable insights through comprehensive industry analysis:

Bioresorbable Scaffolds Market Trends

Lab-on-a-Chip Device Market Growth

Dental Floss Market Demand

Retina Health Market Volume

Skin Cancer Market Forecast